These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8192695)

  • 21. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW; Welzel D; Burger KJ
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute haemodynamic effect of metoprolol in essential hypertension.
    Pechán J; Mikulecký M; Srbecký M
    Cor Vasa; 1988; 30(1):51-9. PubMed ID: 3132353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
    Hayoz D; Tardy Y; Perret F; Waeber B; Meister JJ; Brunner HR
    J Hypertens Suppl; 1992 Jul; 10(5):S95-100. PubMed ID: 1328567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
    Andersson OK; Persson B; Widgren BR; Wysocki M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-four hour profile of the anti-hypertensive action of isradipine in essential hypertension.
    Low CJ; Foy SG; Chaudhary H; Crozier IG; Baskaranathan S; Ikram H
    Blood Press; 1993 Mar; 2(1):59-61. PubMed ID: 8193733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
    Waeber B; Soret P; Poget PN; Brunner HR
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1514-7. PubMed ID: 1465521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
    Yodfat Y; Bar-On D; Amir M; Cristal N
    J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lisinopril and metoprolol on arterial distensibility.
    Barenbrock M; Spieker C; Hoeks AP; Zidek W; Rahn KH
    Hypertension; 1994 Jan; 23(1 Suppl):I161-3. PubMed ID: 8282350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries.
    Megnien JL; Simon A; Valensi P; Flaud P; Merli I; Levenson J
    J Am Coll Cardiol; 1992 Dec; 20(7):1562-8. PubMed ID: 1452931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
    Amir M; Cristal N; Bar-On D; Loidl A
    Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isradipine in arterial hypertension in motor vehicle drivers].
    Aramisova RM; El'garov AA
    Med Tr Prom Ekol; 1996; (8):21-3. PubMed ID: 8963604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension].
    Svetyĭ LI; Alekhin SN
    Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.